Meta-analysis of randomized controlled trials comparing multivessel versus culprit-only revascularization for patients with ST-segment elevation myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 115, Issue 11, 2015, Pages 1481-1486

  El Hayek, Georges E ^a   Gershlick, Anthony H ^b   Hong, Mun K ^a   Dominguez, Abel Casso ^a   Banning, Amerjeet ^b   Afshar, Arash Ehteshami ^a   Herzog, Eyal ^a   Tamis Holland, Jacqueline E ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CULPRIT VESSEL ONLY REVASCULARIZATION; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; COMPARATIVE STUDY; MYOCARDIAL INFARCTION; PROCEDURES;

CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929288763     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.046     Document Type: Article

References (30)

1. J.K. Kahn, B.D. Rutherford, D.R. McConahay, W.L. Johnson, L.V. Giorgi, T.M. Shimshak, R. Ligon, and G.O. Hartzler Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease J Am Coll Cardiol 16 1990 1089 1096
2. D.W. Muller, E.J. Topol, S.G. Ellis, K.N. Sigmon, K. Lee, and R.M. Califf Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group Am Heart J 121 1991 1042 1049
3. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMets, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, and C.W. Yancy 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 485 510
4. M.A. Cavender, S. Milford-Beland, M.T. Roe, E.D. Peterson, W.S. Weintraub, and S.V. Rao Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry) Am J Cardiol 104 2009 507 513
5. P.J. Vlaar, K.D. Mahmoud, D.R. Holmes Jr., G. van Valkenhoef, H.L. Hillege, I.C. van der Horst, F. Zijlstra, and B.J. de Smet Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis J Am Coll Cardiol 58 2011 692 703
6. S. Bangalore, S. Kumar, K.L. Poddar, S. Ramasamy, S.W. Rha, and D.P. Faxon Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease Am J Cardiol 107 2011 1300 1310
7. T. Bauer, U. Zeymer, M. Hochadel, H. Möllmann, F. Weidinger, R. Zahn, H.M. Nef, C.W. Hamm, J. Marco, and A.K. Gitt Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry Int J Cardiol 166 2013 596 600
8. M. Toma, C.E. Buller, C.M. Westerhout, Y. Fu, W.W. O'Neill, D.R. Holmes Jr., C.W. Hamm, C.B. Granger, P.W. Armstrong APEX-AMI Investigators Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial Eur Heart J 31 2010 1701 1707
9. C. Di Mario, S. Mara, A. Flavio, S. Imad, M. Antonio, P. Anna, P. Emanuela, D.S. Stefano, R. Angelo, C. Stefania, F. Anna, C. Carmelo, C. Antonio, N. Monzini, and M.A. Bonardi Single vs multivessel treatment during primary angioplasty: results of the multicentre randomized HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study Int J Cardiovasc Intervent 6 2004 128 133
10. A. Ochala, G.A. Smolka, W. Wojakowski, D. Dudek, A. Dziewierz, Z. Krolikowski, Z. Gasior, and M. Tendera The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction J Invasive Cardiol 16 2004 699 702
11. L. Politi, F. Sgura, R. Rossi, D. Monopoli, E. Guerri, C. Leuzzi, F. Bursi, G.M. Sangiorgi, and M.G. Modena A randomised trial of target-vessel versus multi-vessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up Heart 96 2010 662 667
12. D.S. Wald, J.K. Morris, N.J. Wald, A.J. Chase, R.J. Edwards, L.O. Hughes, C. Berry, K.G. Oldroyd PRAMI Investigators Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 369 2013 1115 1123
13. A.H. Gershlick, J. Nasir Khan, D.J. Kelly, J.P. Greenwood, T. Sasikaran, N. Curzen, D.J. Blackman, M. Dalby, K.L. Fairbrother, W. Banya, D. Wang, M. Flather, S.L. Hetherington, A.D. Kelion, S. Talwar, M. Gunning, R. Hall, H. Swanton, and G.P. McCann Randomised trial of complete versus lesion only revascularization in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction and multivessel disease: the Complete versus Lesion-only Primary PCI Trial (CvLPRIT) J Am Coll Cardiol 65 2015 963 972
14. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
15. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available at: www.cochrane-handbook.org. Accessed on October 2014.
16. W. Maamoun, N. Elkhaeat, and R. Elarasy Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel disease Egypt Heart J 63 2011 39 43
17. J.H. Dambrink, J.P. Debrauwere, A.W. van 't Hof, J.P. Ottervanger, A.T. Gosselink, J.C. Hoorntje, M.J. de Boer, and H. Suryapranata Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? EuroIntervention 5 2010 968 975
18. H.C. Chen, T.H. Tasi, H.Y. Fang, C.K. Sun, Y.C. Lin, S. Leu, S.Y. Chung, H.T. Chai, C.H. Yang, Y.K. Hsien, C.J. Wu, and H.K. Yip Benefit of revascularization in non-infarct-related artery in multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Int Heart J 51 2010 319 324
19. R. Jeger, M. Jaguszewski, B.N. Nallamothu, T.F. Lüscher, P. Urban, G.B. Pedrazzini, P. Erne, D. Radovanovic AMIS Plus Investigators Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry Int J Cardiol 172 2014 76 81
20. A. Manari, E. Varani, P. Guastaroba, M. Menozzi, M. Valgimigli, A. Menozzi, P. Magnavacchi, N. Franco, A. Marzocchi, and G. Casella Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: insights from the REAL registry Catheter Cardiovasc Interv 84 2014 912 922
21. E.L. Hannan, Z. Samadashvili, G. Walford, D.R. Holmes Jr., A.K. Jacobs, N.J. Stamato, F.J. Venditti, S. Sharma, and S.B. King III Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease JACC Cardiovasc Interv 3 2010 22 31
22. M.T. Roe, F.A. Cura, P.S. Joski, E. Garcia, V. Guetta, D.J. Kereiakes, F. Zijlstra, B.R. Brodie, C.L. Grines, and S.G. Ellis Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction Am J Cardiol 88 2001 170 173
23. Y.L. Han, B. Wang, X.Z. Wang, Y. Li, S.L. Wang, Q.M. Jing, G. Wang, Y.Y. Ma, and B. Luan Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease Chin Med J 121 2008 2384 2387
24. H.W. Lee, T.J. Hong, M.J. Yang, S.G. An, J.H. Oh, J.H. Choi, H.C. Lee, K.S. Cha, J.Y. Hong Korea Acute Myocardial Infarction Registry Investigators Comparison of infarct-related artery vsmultivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry Cardiol J 19 2012 256 266
25. M. Jaguszewski, D. Radonovic, B.K. Nallamothu, T.F. Lüscher, P. Urban, F.R. Eberli, O. Bertel, G.B. Pedrazzini, S. Windecker, R. Jeger, P. Erne AMIS Plus Investigators Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse? EuroIntervention 9 2013 909 915
26. R.A. Corpus, J.A. House, S.P. Marso, J.A. Grantham, K.C. Huber Jr., S.B. Laster, W.L. Johnson, W.C. Daniels, C.W. Barth, L.V. Giorgi, and B.D. Rutherford Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction Am Heart J 143 2004 493 500
27. E. Meliga, C. Riorina, B.M. Valgimigli, R. Belli, A. Gagnor, I. Sheiban, C. Resmini, E. Tizzani, T. Aranzulla, I. Scrocca, M. DE Benedictis, and M.R. Conte Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease J Interv Cardiol 24 2011 535 541
28. M.B. Iqbal, C. Ilsley, T. Kabi, R. Smith, R. Lane, M. Mason, P. Clifford, T. Crake, S. Firoozi, S. Kalra, C. Knight, P. Lim, I.S. Malik, A. Mathur, P. Meier, R.D. Rakhit, S. Redwood, M. Whitbread, D. Bromage, K. Rathod, P. MacCarthy, M. Dalby London Heart Attack Centre (HAC) Group Investigators Culprit vessel VersusMultivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease. Real-World analysis of 3984 patients in London Circ Cardiovasc Qual Outcomes 7 2014 936 943
29. J.A. Goldstein, D. Demetriou, C.L. Grines, M. Pica, M. Shoukfeh, and W.W. O'neill Multiple complex plaques in patients with acute myocardial infarction N Engl J Med 343 2000 915 922
30. R. Kornowski, R. Mehran, G. Dangas, E. Nikolsky, A. Assali, B.E. Claessen, B.J. Gersh, S.C. Wong, B. Witzenbichler, G. Guagliumi, D. Dudek, M. Fahy, A.J. Lansky, G.W. Stone HORIZONS-AMITrial Investigators Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol 58 2011 704 711